Latest News

sleep
Positive Topline Results From Phase 3 Trial of AD109, First Oral Pill for Obstructive Sleep Apnea

July 23rd 2025

Apnimed reveals promising results for AD109, a groundbreaking oral treatment for obstructive sleep apnea.

narcolepsy
Positive Phase 2 Data: Alixorexton for the Treatment of Adults With Narcolepsy Type 1

July 21st 2025

sleep
What Is a Sleep Disorder? A Harmful Dysfunction Analysis

June 24th 2025

night
Beyond the Night: Unraveling the Psychiatric Impact of Sleep Disorders

June 23rd 2025

insomnia
Promoting Insomnia Management in the Context of Psychiatric Symptoms

June 20th 2025

Latest CME Events & Activities

SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era

View More

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

View More

Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists

View More

BURST CME™ Part I: Understanding the Impact of Huntington’s Disease

View More

Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease

View More

Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea

View More

Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment

View More

PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia

View More

Southern Florida Psychiatry Conference

November 21-22, 2025

Register Now!

Real Psychiatry 2026

January 23-24, 2026

View More

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

View More

Optimizing Care for Patients With Tardive Dyskinesia

View More

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

View More

More News

© 2025 MJH Life Sciences

All rights reserved.